Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients
Withdrawn before enrolling
Georgetown UniversityPhase 2 NCT05479045 Registry history of NCT05479045 on ClinicalTrials.gov (opens the registry)
7 trials changed in the last 30 days: 1 stopped, 3 with notable changes, 3 with minor changes only.
Withdrawn before enrolling
Georgetown UniversityPhase 2 NCT05479045 Registry history of NCT05479045 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Dec 31, 2026 to Aug 31, 2027
Also in this update: Sponsor changed: Emory University to Georgetown University
Georgetown UniversityPhase 2 NCT06423326 Registry history of NCT06423326 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Dec 31, 2025 to Dec 31, 2026
Also in this update: Enrollment closed, study ongoing; Study completion pushed from Feb 28, 2026 to Feb 28, 2027
Georgetown UniversityNot applicable NCT04675476 Registry history of NCT04675476 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Apr 30, 2025 to Apr 30, 2027
Georgetown UniversityNot specified NCT03451383 Registry history of NCT03451383 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Final enrollment: 11 participants (planned 20); Primary completion date changed from estimate of Dec 2026 to Aug 20, 2026
Georgetown UniversityPhase 3 NCT05482516 Registry history of NCT05482516 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 174 participants (planned 200)
Georgetown UniversityNot applicable NCT07084233 Registry history of NCT07084233 on ClinicalTrials.gov (opens the registry)
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Georgetown UniversityNot applicable NCT04258280 Registry history of NCT04258280 on ClinicalTrials.gov (opens the registry)
Changed
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-01 | NCT07852247 SBRT for Ultra-Central NonSmall Cell Lung Cancer | Phase 1 | Not Yet Recruiting |
| Phase 1 | 2 | |
| Phase 1/2 | 4 | |
| Phase 2 | 16 | |
| Phase 3 | 2 |
Breast Cancer (7) · Lung Cancer (7) · Non-Small Cell Lung Cancer (NSCLC) (5) · Pancreatic Cancer (5) · Anxiety (4) · Head & Neck Cancer (4) · Prostate Cancer (4) · Stroke (4) · Depression (3) · Ovarian Cancer (3)